This company listing is no longer active
INCR.U Stock Overview
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
InterCure Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪1.53 |
| 52 Week High | ₪5.82 |
| 52 Week Low | ₪1.47 |
| Beta | 0.016 |
| 1 Month Change | -6.71% |
| 3 Month Change | -33.48% |
| 1 Year Change | -73.71% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| INCR.U | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -7.8% | -1.8% | -0.6% |
| 1Y | -73.7% | 50.8% | 3.9% |
Return vs Industry: INCR.U underperformed the Canadian Pharmaceuticals industry which returned -56.5% over the past year.
Return vs Market: INCR.U underperformed the Canadian Market which returned -1.8% over the past year.
Price Volatility
| INCR.U volatility | |
|---|---|
| INCR.U Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: INCR.U's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine INCR.U's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 370 | Alex Rabinovitch | www.intercure.co |
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector.
InterCure Ltd. Fundamentals Summary
| INCR.U fundamental statistics | |
|---|---|
| Market cap | US$69.45m |
| Earnings (TTM) | US$8.44m |
| Revenue (TTM) | US$108.69m |
8.2x
P/E Ratio0.6x
P/S RatioIs INCR.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INCR.U income statement (TTM) | |
|---|---|
| Revenue | ₪407.63m |
| Cost of Revenue | ₪237.01m |
| Gross Profit | ₪170.63m |
| Other Expenses | ₪138.97m |
| Earnings | ₪31.66m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 41.86% |
| Net Profit Margin | 7.77% |
| Debt/Equity Ratio | 33.0% |
How did INCR.U perform over the long term?
See historical performance and comparison